Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Secures $1.1M in Highly Dilutive Equity Offering at Deep Discount

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.31
Mkt Cap
$1.518M
52W Low
$1.28
52W High
$171.5
52W Position info
2.3% above low
Off High info
99% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ELAB is trading near its 52-week low of $1.28 (2.3% above the low) on light trading volume (0.3× avg).

Summary

PMGC Holdings Inc. announced a new tranche of its equity line of credit, raising $1.1 million through the issuance of common stock at a significant discount, further diluting existing shareholders.


Key Events · Financing and Capital Events · ELAB

  • New Equity Tranche

    The company is raising $1.1 million in net proceeds through the Fourth Pre-Paid Purchase under its existing Equity Line of Credit (ELOC) with Streeterville Capital, LLC, with an anticipated closing date of February 18, 2026.

  • Significant Dilution

    This capital raise represents approximately 73% of the company's current market capitalization, indicating substantial dilution for existing shareholders.

  • Deep Discount Pricing

    Shares will be issued at 88% of the lowest daily volume-weighted average price (VWAP) over a ten-day period, subject to floor prices, which is a highly unfavorable pricing structure.

  • Going Concern Warning

    The company's financial statements include a "going concern" warning, underscoring its critical need for capital to support operations and potential acquisitions.


Analysis · ELAB · Life Sciences

This 424B5 filing details the terms of the Fourth Pre-Paid Purchase under an existing Equity Line of Credit (ELOC) with Streeterville Capital, LLC, securing $1.1 million in net proceeds. This transaction is highly dilutive, representing approximately 73% of the company's current market capitalization. The shares will be issued at a substantial discount (88% of the lowest daily VWAP over ten trading days), which is particularly unfavorable given the stock is trading near its 52-week low. The company continues to operate under a "going concern" warning, indicating a critical need for capital to sustain operations and fund potential acquisitions. This financing, while providing immediate liquidity, comes at a significant cost to existing shareholders and highlights the company's precarious financial position.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 51.2% of the 201 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.73%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ELAB was trading at $1.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $1.28 to $171.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Nov 02, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $1.60 info
Change: -$0.5196 (-25%) info
Market Cap: $1.336M info
ELAB
Oct 01, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.60 info
Change: -$2.02 (-56%) info
Market Cap: $1.336M info
ELAB
Sep 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $1.60 info
Change: -$3.10 (-66%) info
Market Cap: $1.336M info
ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $1.60 info
Change: -$3.60 (-69%) info
Market Cap: $1.336M info
ELAB
Sep 01, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.23
Real-time Price: $1.60 info
Change: -$3.63 (-69%) info
Market Cap: $1.336M info